Select date

May 2024
Mon Tue Wed Thu Fri Sat Sun

Criminal Big-Pharma Put in Charge of Covid-19 “Vaccine”

2-5-2020 < SGT Report 12 859 words
 

by Tony Cartalucci, New Eastern Outlook:



Big-Pharma – guilty of lying, cheating, stealing, bribery, and a history of exposing the public to dangerous and even deadly drugs – is being given billions to develop a Covid-19 “vaccine.” Would you trust your health to these criminals? 


Coronavirus Disease 2019 or “Covid-19″ hysteria is sweeping the globe – with mass media-induced public panic paralyzing entire nations, gutting economies of billions as workplaces are shutdown and the public shuttered indoors all while exposed to 24 hour news cycles deliberately fanning the flames of fear.



The West’s healthcare industry is already profiting both monetarily and in terms of artificial credibility as a panicked public turn to it for answers and safety.Waiting to cash in on offering “cures” and “vaccines” for a virus is the immensely corrupt Western pharmaceutical industry in particular – notorious corporations like GlaxoSmithKline (GSK), Novartis, Bayer, Merck, Johnson and Johnson, Pfizer, Lilly, and Gilead.


All corporations – without exception – pursuing government-funded vaccines and therapies for Covid-19 are corporations guilty and repeatedly convicted in courts of law around the globe of crimes including falsifying research, safety, and efficacy studies, bribing researchers, doctors, regulators, and even law enforcement officials, and marketing drugs that were either entirely ineffective or even dangerous.



Government funding from taxpayers across the Western World are being funneled into supposedly non-profit organizations like the Coalition for Epidemic Preparedness Innovation (CEPI) which are in actuality fronts created and chaired by big-pharma to avoid investing their own money into costly research and development and simply profit from whatever emerges from state-funded research.


CEPI – for example – is receiving billions in government funds from various nations that will be used for R&D that results in products sold by and profited from big-pharma.



Novartis – Plumbing the Depths of the Despicable 


A particularly shocking and appalling example comes from Swiss pharmaceutical giant Novartis – who is currently attempting to ram through approval of its drug Jakafi as a therapy for severe Covid-19 patients.


A University of Pennsylvania team headed by Dr. Carl June and funded entirely by charity had developed a gene therapy that fully and permanently cured leukemia patients who had otherwise failed to respond to more traditional treatments like bone marrow transplants. During early trials in 2010-2012, one patient – a 6 year old named Emily Whitehead – was literally on her death bed before receiving the revolutionary gene therapy.Today she is alive and well, in permanent remission.


What is more astounding about the therapy is that it is administered only one time. That is because after administration the patient’s cells are rewired permanently to fight off cancer. Old cells pass the cancer-fighting information off to new cells as they divide and multiply.


The therapy developed by Dr. June’s team is not only a one-time therapy, it is also incredibly cost effective. Under experimental conditions the procedure cost under 20,000 USD. Dr. June at a 2013 talk at The Society for Translational Oncology would state:


So the cost of goods, it’s interesting. The major cost here is gamma globulin. So the t-cells themselves, with us, for our in-house costs of an apheresis and so on is 15,000 dollars to manufacture the t-cells. 



The charity that funded Dr. June’s team – Leukemia & Lymphoma Society (LLS) – would see its work sold off to Novartis, approved by the FDA in 2017 and marketed as Kymriah. What was noted by Dr. June himself as costing 15,000 USD to produce under experimental conditions was marked up by Novartis to an astronomical half-million dollars. The New York Times article that reported the drug’s cost never mentions the actual cost of the drug and instead defers to Novartis’ own explanation as to why the drug was so expensive.


The NYT had previously reported on the therapy’s progress before its acquisition by Novartis, yet NYT writers failed to hold Novartis accountable or inform readers of the actual cost of the therapy and expose price gouging by Novartis. This helps illustrate the mass media’s role in enabling and covering up for big-pharma’s corruption.


Upon closer examination – and no thanks to publications like NYT – it turns out LLS was and still is in partnership with Novartis and while it denied Novartis had anything to do with the gene therapy funded by LLS and ultimately sold to Novartis – the glaring conflict of interest remains and fits in perfectly with the wider pharmaceutical industry’s track record of corruption, abuse, and placing profits before human life.


The Novartis example is a microcosm of how the entire industry operates and indeed – precisely how it already is exploiting and profiting from Covid-19 hysteria where hard-working researchers have their work funded by shady “charities” only to be bought up by big-pharma and dangled over the heads of the desperate for movie-villain ransoms – all in cooperation with a complicit government and mass media.


Read More @ Journal-NEO.org





Loading...




Print